Park-Wyllie, L., Mazzotta, P., Pastuszak, A., Moretti, M. E., Beique, L., Hunnisett, L., … Koren, G. (2000). Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology, 62 (6), 385-392. Patel, D. N. (2013). Inconclusive results of a systematic review of efficacy of antidepressants on orofacial pain disorders. Evidence-Based Dentistry, 14 (2), 55-56. Pope, J. E., & Deer, T. R. (2013). Ziconotide: A clinical update and pharmacologic review. Expert Opinion on Pharmacotherapy, 14 (7), 957- 966. Reyad, A.A., Mishriky, R., & Girgis, E. (2020). Pharmacological and non-pharmacological management of burning mouth syndrome: A systematic review. Dent and Medical Problems, 57 (3), 295-304. Rotpenpian, N., & Yakkaphan, P. (2021). Review of Literatures: Physiology of Orofacial Pain in Dentistry. eNeuro, 8 (2):ENEURO.0535- 20.2021. Serrano Afonso, A., Carnaval, T., & Videla Cés, S. (2021). Combination Therapy for Neuropathic Pain: A Review of Recent Evidence. Journal of Clinical Medicine, 10 (16), 3533. Settipane, R. A., Schrank, P. J., Simon, R. A., Mathison, D. A., Christiansen, S. C., & Stevenson, D. D. (1995). Prevalence of cross- sensitivity with acetaminophen in aspirin- sensitive asthmatic subjects . Journal of Allergy and Clinical Immunology, 96 (4), 480-485. Ślebioda, Z., Lukaszewska-Kuska, M., & Dorocka-Bobkowska, B. (2020). Evaluation of the efficacy of treatment modalities in burning mouth syndrome-A systematic review. Journal of Oral Rehabilitation, 47 (11), 1435-1447. Smaïl-Faugeron, V., Courson, F., & Arrêto, C. D. (2013). Assessment and management of chronic orofacial pain associated with a disease in children: A multidisciplinary approach. Acta Paediatrica, 102 (8), 778-786. Stentz, D., Drum, M., Reader, A., Nusstein, J., Fowler, S., & Beck, M. (2018). Effect of a Combination of Intranasal Ketorolac and Nitrous Oxide on the Success of the Inferior Alveolar Nerve Block in Patients with Symptomatic Irreversible Pulpitis: A Prospective, Randomized, Double-blind Study. Journal of Endodontics, 44 (1), 9-13. Stern, I., & Greenberg, M. S. (2013). Clinical assessment of patients with orofacial pain and temporomandibular disorders. Dental Clinics of North America, 57 (3), 393-404. Sun, A., Wu, K. M., Wang, Y. P., Lin, H. P., Chen, H. M., & Chiang, C. P. (2013). Burning mouth syndrome: A review and update. Journal of Oral Pathology & Medicine, 42 (9), 649-655. Szok, D., Tajti, J., Nyári, A., & Vécsei, L. (2019). Therapeutic Approaches for Peripheral and Central Neuropathic Pain. Behavioral Neurology : 8685954. Thoppay, J. R., De Rossi, S. S., & Ciarrocca, K. N. (2013). Burning mouth syndrome. Dental Clinics of North America, 57 (3), 497-512. Thorpe, P. G., Gilboa, S. M., Hernandez-Diaz, S., Lind, J., Cragan, J. D., Briggs, G., … Honein, M. A. (2013). Medications in the first trimester of pregnancy: Most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiology and Drug Safety, 22 (9), 1013-1018.
Torfs, C. P., Katz, E. A., Bateson, T. F., Lam, P. K., & Curry, C. J. (1996). Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology, 54 (2), 84-92. Treede, R. D., Jensen, T. S., Campbell, J. N., Cruccu, G., Dostrovsky, J. O., Griffin, J. W., … Serra, J. (2008). Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology, 70( 18), 1630-1635. U.S. Department of Health and Human Services. (2008). FDA pregnancy categories . Retrieved from http://chemm.nlm.nih.gov/pregnancycategories.htm. U.S. Department of Justice Drug Enforcement Administration, Diversion Control Division. Rules—2014. (2014). Retrieved from: https://www.deadiversion.usdoj.gov/fed_regs/ rules/2014/fr0822.htm. U.S. Drug Enforcement Administration. Drug Scheduling. (2019). Retrieved from: https:// www.dea.gov/drug-scheduling. U.S. Food and Drug Administration (2016). Pregnancy and lactation labeling final rule [online]. Retrieved from: https://www.gpo.gov/fdsys/pkg/CFR-2016-title21-vol4/xml/CFR- 2016-title21-vol4-sec201-57.xml. U.S. Food and Drug Administration (2020). Pregnancy, Lactation, and Reproductive Potential: Labeling for Human Prescription Drug and Biological Products-Content and Format: Draft Guidance for Industry,” [online]. Retrieved from: https://www.fda. gov/regulatory- information/search-fda-guidance-documents/pregnancy-lactation-and- reproductive-potential-labeling-human-prescription-drug-and- biological. Vadivelu, N., Gowda, A. M., Urman, R. D., Jolly, S., Kodumudi, V., Maria, M., Taylor, R. Jr., & Pergolizzi, J. V. Jr. (2015). Ketorolac tromethamine - routes and clinical implications. Pain Practice, 15 (2), 175-93. Varvara, G., Bernardi, S., Cutilli, T., Bianchi, S., Sinjari, B., & Piattelli, M. (2017). Anti- inflammatory steroid use in impacted third molar surgery: a systematic review. Journal of Biological Regulators and Homeostatic Agents,31( 4),1095-1099. Washington State Legislature. (2021). WAC 246-817-977 Coprescribing of naloxone. Retrieved from: https://app.leg.wa.gov/wac/default.spx?cite=246-817-977. Xu, Z., Zhang, H., Luo, J., Zhou, A., & Zhang, J. (2017). Preemptive analgesia by using celecoxib combined with tramadol/APAP alleviates post-operative pain of patients undergoing total knee arthroplasty. The Physician and Sports Medicine, 45( 3), 316-322. Zakrzewska, J. M. (2009). Facial pain: An update. Current Opinion in Supportive and Palliative Care, 3 (2), 125-130. Zakrzewska, J. M. (2013). Differential diagnosis of facial pain and guidelines for management. British Journal of Anaesthesia, 111 (1), 95- 104. Zhang, X., Yang, Q., & Zhang, Z. (2017). The efficiency and safety of local liposomal bupivacaine infiltration for pain control in total hip arthroplasty: A systematic review and meta-analysis. Medicine (Baltimore), 96 (49), e8433. 222. One hallmark sign of neuropathic pain is an extreme sensitivity to pain secondary to touch, also known as: a. Mechanical hyperalgesia. b. Allodynia. c. Somatic pain. d. Paresthesia. 223. One class of drugs considered to be a mainstay treatment for neuropathic pain is: a. Narcotic pain medications. b. Anticonvulsant medications. c. Non-narcotic pain medications. d. Beta blockers. 224. Adjuvant pharmacotherapy for orofacial pain includes four major classes of medications: antidepressants, anticonvulsants, anxiolytics, and: a. Anticholinergics. b. Beta blockers. c. Muscle relaxants. d. Proton pump inhibitors. 225. Based on the findings of three large-scale studies, the safest analgesic for a pregnant patient is: a. Aspirin. 226. According to the American Academy of Pediatrics, if a practitioner chooses to prescribe a narcotic to a patient who is breastfeeding, the safest medication is a. Vicoprofen. b. Codeine. c. Hydrocodone. d. Aspirin. b. Codeine. c. Ibuprofen. d. Acetaminophen.
THREE DRUG CLASSES: ANTIBIOTICS, ANALGESICS, AND LOCAL ANESTHETICS MOD II: ANALGESICS, 3RD EDITION Final Examination Questions Select the best answer for each question complete your test online at EliteLearning.com/Book 217. Orofacial pain that results from tissue injury and inflammation is known as:
a. Nociceptive pain. b. Neuropathic pain.
c. Visceral pain. d. Phantom pain. 218. Which inflammatory mediators are especially important for sensitizing peripheral neurons? a. Leukotrienes. b. Prostaglandins. c. Kinins. d. Histamines. 219. Aspirin and related NSAIDs prevent prostaglandin formation by inhibiting the activity of: c. Cyclooxygenase (COX). d. Cytochrome P450 (CYP). 220. Aspirin and related NSAIDs have side effects that include delayed wound healing, gastroduodenopathies, an increased risk of cardiovascular events, and: a. Secondary inflammation. a. Histamine. b. Endorphins.
b. Prolonged bleeding. c. Immune suppression. d. Respiratory distress.
221. In treating nociceptive pain, a superior analgesic effect has been achieved using nonsteroidal anti-inflammatory drugs (NSAIDs) in combination with: a. Vicoprofen.
b. Codeine. c. Ibuprofen. d. Acetaminophen.
Course Code: DFL02AG
EliteLearning.com/ Dental
Book Code: DHFL2624
Page 179
Powered by FlippingBook